Abstract Body

HIV-1 uncoating (capsid core disassembly) is a prerequisite for viral DNA integration into the host genome and a promising target for antiviral therapy. However, the timing and cellular location of uncoating remain elusive, in part because current methods are unable to directly and accurately measure the amount of capsid protein (CA) loss from the infectious viral complexes. Bulk measurement of CA loss by biochemical methods or imaging of viral complexes may not reflect the behavior of infectious viral complexes, since only a small fraction of the viral complexes in the cell lead to infection. Quantification of CA by immunostaining with anti-CA antibody or live-cell imaging of viral complexes labeled with fluorescently-tagged cyclophilin A (CypA) is confounded by loss of epitope accessibility to the antibody or loss of interactions to CypA.

We developed a method to directly label CA with green fluorescent protein (GFP) in infectious viral complexes, determined virus infectivity in HeLa and CEM-SS cells, characterized GFP-CA core incorporation and stability by sucrose gradient fractionation and Western blot, and quantified the core-associated CA during nuclear import using live-cell imaging.

The GFP-CA labeling method is highly efficient and results in >96% of the virions being fluorescently labeled. Importantly, the GFP-CA labeling resulted in only a ~2-fold loss of virus infectivity in HeLa and CEM-SS T cells, indicating that GFP-CA-labeled viral complexes are infectious. Sucrose-gradient fractionation of virions indicated that GFP-CA was incorporated into viral cores and did not affect the core stability. Moreover, analysis of infected HeLa cells indicated that GFP-CA-labeled cores can efficiently associate with the nuclear envelope and enter the nucleus. We analyzed the amount of GFP-CA associated with viral cores docked at the nuclear envelope just before and after their translocation into the nucleus. No significant loss of GFP-CA was observed in the nuclear viral complexes compared to those at the nuclear envelope, indicating that uncoating does not occur during nuclear import.

These studies provide a new robust method for quantification of CA associated with viral complexes and will facilitate studies of HIV-1 post-entry events.  Our results do not support the model that viral core uncoating occurs during nuclear import.